BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 10443649)

  • 21. Food-dependent Cushing's syndrome: characterization and functional role of gastric inhibitory polypeptide receptor in the adrenals of three patients.
    Lebrethon MC; Avallet O; Reznik Y; Archambeaud F; Combes J; Usdin TB; Narboni G; Mahoudeau J; Saez JM
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4514-9. PubMed ID: 9851802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of ACTH receptor pathway genes in glucose-dependent insulinotrophic peptide (GIP)-dependent Cushing's syndrome.
    Antonini SR; Baldacchino V; Tremblay J; Hamet P; Lacroix A
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):29-36. PubMed ID: 16402925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cushing's syndrome in a patient with bilateral macronodular adrenal hyperplasia responding to cisapride: an in vivo and in vitro study.
    Mannelli M; Ferruzzi P; Luciani P; Crescioli C; Buci L; Corona G; Serio M; Peri A
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4616-22. PubMed ID: 14557431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A patient with recurrent hypercortisolism after removal of an ACTH-secreting pituitary adenoma due to an adrenal macronodule.
    Timmers HJ; van Ginneken EM; Wesseling P; Sweep CG; Hermus AR
    J Endocrinol Invest; 2006 Nov; 29(10):934-9. PubMed ID: 17185905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Illicit hormone receptors in adrenal Cushing's syndrome].
    Lacroix A
    Ann Endocrinol (Paris); 2001 Apr; 62(2):185-8. PubMed ID: 11353892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case of adrenocorticotropic hormone-independent macronodular adrenal hyperplasia with possible adrenal hypersensitivity to angiotensin II.
    Nakamura Y; Son Y; Kohno Y; Shimono D; Kuwamura N; Koshiyama H; Sasano H; Matsuda T
    Endocrine; 2001 Jun; 15(1):57-61. PubMed ID: 11572327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Food-dependent Cushing syndrome of long standing with mild clinical features].
    Gerl H; Rohde W; Biering H; Schulz N; Lochs H
    Dtsch Med Wochenschr; 2000 Dec; 125(51-52):1565-8. PubMed ID: 11199448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome.
    Bourdeau I; D'Amour P; Hamet P; Boutin JM; Lacroix A
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5534-40. PubMed ID: 11701732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome: a multicentre, retrospective, cohort study.
    Chasseloup F; Bourdeau I; Tabarin A; Regazzo D; Dumontet C; Ladurelle N; Tosca L; Amazit L; Proust A; Scharfmann R; Mignot T; Fiore F; Tsagarakis S; Vassiliadi D; Maiter D; Young J; Lecoq AL; Deméocq V; Salenave S; Lefebvre H; Cloix L; Emy P; Dessailloud R; Vezzosi D; Scaroni C; Barbot M; de Herder W; Pattou F; Tétreault M; Corbeil G; Dupeux M; Lambert B; Tachdjian G; Guiochon-Mantel A; Beau I; Chanson P; Viengchareun S; Lacroix A; Bouligand J; Kamenický P
    Lancet Diabetes Endocrinol; 2021 Dec; 9(12):813-824. PubMed ID: 34655521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PRKAR1A-negative familial Cushing's syndrome: two case reports.
    Lim LL; Kitan N; Paramasivam SS; Ratnasingam J; Ibrahim L; Chan SP; Tan AT; Vethakkan SR
    J Med Case Rep; 2015 Dec; 9():277. PubMed ID: 26619967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial adrenocorticotropin-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia.
    Findlay JC; Sheeler LR; Engeland WC; Aron DC
    J Clin Endocrinol Metab; 1993 Jan; 76(1):189-91. PubMed ID: 8380604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastric inhibitory polypeptide (GIP) stimulates cortisol secretion, cAMP production and DNA synthesis in an adrenal adenoma responsible for food-dependent Cushing's syndrome.
    Chabre O; Liakos P; Vivier J; Bottari S; Bachelot I; Chambaz EM; Feige JJ; Defaye G
    Endocr Res; 1998; 24(3-4):851-6. PubMed ID: 9888586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cushing's syndrome due to bilateral adrenal macronodular hyperplasia. From ACTH-dependent hypercortisolism to ACTH-independent hypercortisolism].
    López JM; Sapunar J; Donoso J; Martínez P
    Rev Med Chil; 1991 Oct; 119(10):1165-70. PubMed ID: 1668993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia: an unusual cause of Cushing's syndrome.
    Malchoff CD; Rosa J; DeBold CR; Kozol RA; Ramsby GR; Page DL; Malchoff DM; Orth DN
    J Clin Endocrinol Metab; 1989 Apr; 68(4):855-60. PubMed ID: 2537845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia.
    Louiset E; Duparc C; Young J; Renouf S; Tetsi Nomigni M; Boutelet I; Libé R; Bram Z; Groussin L; Caron P; Tabarin A; Grunenberger F; Christin-Maitre S; Bertagna X; Kuhn JM; Anouar Y; Bertherat J; Lefebvre H
    N Engl J Med; 2013 Nov; 369(22):2115-25. PubMed ID: 24283225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cushing's syndrome due to ACTH-independent bilateral adrenocortical macronodular hyperplasia.
    Terzolo M; Boccuzzi A; Ali A; Bollito E; De Risi C; Paccotti P; Angeli A
    J Endocrinol Invest; 1997 May; 20(5):270-5. PubMed ID: 9258806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extensive expertise in endocrinology: glucose-dependent insulinotropic peptide-dependent Cushing's syndrome.
    Lacroix A
    Eur J Endocrinol; 2023 Mar; 188(3):R56-R72. PubMed ID: 36857084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo and in vitro effects of AVP and V1a receptor antagonist on Cushing's syndrome due to ACTH-independent bilateral macronodular adrenocortical hyperplasia.
    Daidoh H; Morita H; Hanafusa J; Mune T; Murase H; Sato M; Shibata T; Suwa T; Ishizuka T; Yasuda K
    Clin Endocrinol (Oxf); 1998 Sep; 49(3):403-9. PubMed ID: 9861334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Luteinizing hormone (LH)-responsive Cushing's syndrome: the demonstration of LH receptor messenger ribonucleic acid in hyperplastic adrenal cells, which respond to chorionic gonadotropin and serotonin agonists in vitro.
    Feelders RA; Lamberts SW; Hofland LJ; van Koetsveld PM; Verhoef-Post M; Themmen AP; de Jong FH; Bonjer HJ; Clark AJ; van der Lely AJ; de Herder WW
    J Clin Endocrinol Metab; 2003 Jan; 88(1):230-7. PubMed ID: 12519858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The diversity of abnormal hormone receptors in adrenal Cushing's syndrome allows novel pharmacological therapies.
    Lacroix A; N'Diaye N; Mircescu H; Tremblay J; Hamet P
    Braz J Med Biol Res; 2000 Oct; 33(10):1201-9. PubMed ID: 11004721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.